Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
Claudia G. Benítez‐Cardoza, José Luis Vique‐Sánchez
Topics & Concepts
ADMEDocking (animal)PharmacologyCoronavirus disease 2019 (COVID-19)ToxicitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Computational biologyVirtual screeningDrugIn vitroChemistryBiochemistryDrug discoveryBiologyMedicineDiseaseInfectious disease (medical specialty)Veterinary medicineOrganic chemistryPathologyCOVID-19 Clinical Research StudiesRenin-Angiotensin System StudiesDiverse Scientific Research Studies